ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PDGI Pharmanet Development Grp (MM)

5.04
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Pharmanet Development Grp (MM) NASDAQ:PDGI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.04 0 01:00:00

Law Offices of Howard G. Smith Announces Class Action Lawsuit on Behalf of Investors of PharmaNet Development Group, Inc.

23/11/2008 9:10pm

PR Newswire (US)


Pharmanet Development Grp (MM) (NASDAQ:PDGI)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Pharmanet Development Grp (MM) Charts.
BENSALEM, Pa., Nov. 23 /PRNewswire/ -- Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey against PharmaNet Development Group, Inc. ("PharmaNet" or the "Company") (NASDAQ:PDGI), on behalf of all persons who purchased or otherwise acquired the Company's common stock between November 1, 2007 and April 30, 2008. The complaint alleges that the Company and certain of its executive officers violated federal securities laws. Specifically, the complaint alleges that certain public statements made by PharmaNet during that period were materially false and misleading because the statements failed to disclose or indicate, among other things: (1) that a substantial portion of the contracts in the Company's backlog were likely to be cancelled; (2) that the Company had increased its expenses in order to perform these contracts even though the contracts were likely to be cancelled; and (3) that as a result, statements made by the Company and management during that period about the Company's business, operations, and prospects lacked a reasonable basis. On April 30, 2008 PharmaNet announced that it was revising downward its previously issued revenue guidance for 2008. The Company explained that cancellations over the fourth quarter of 2007 and the first quarter of 2008 of approximately $59 million would negatively impact projected revenues for 2008 by approximately $30 million. On this news, PharmaNet's shares declined $6.76 per share, or 28.33 percent, to close on May 1, 2008 at $17.10 per share, on unusually heavy trading volume. If you are a member of the class described above, you may move the Court, no later than January 19, 2009 to serve as lead plaintiff, however, you must meet certain legal requirements. If you purchased PharmaNet's common stock between November 1, 2007 and April 30, 2008 or if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to . DATASOURCE: Law Offices of Howard G. Smith CONTACT: Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, +1-215-638-4847, or 1-888-638-4847,

Copyright

1 Year Pharmanet Development Grp (MM) Chart

1 Year Pharmanet Development Grp (MM) Chart

1 Month Pharmanet Development Grp (MM) Chart

1 Month Pharmanet Development Grp (MM) Chart

Your Recent History

Delayed Upgrade Clock